Citations

Showing 10 of 108094 citations.

The undue influence of significant p-values on the perceived importance of study results
Bhandari, Mohit , Montori, Víctor M. , Montori, Victor M , Schemitsch, Emil H.

Mayo Clinic

Acta Orthopaedica | July 2, 2018 | Volume: 76 | Issue: 3 | Pages: 291-295

10.1080/00016470510030724 Get It

Smoking and Risk of Non-Hodgkin Lymphoma Subtypes in a Cohort of Older Women
Parker, Alex S., Dick, Fred R., Kemp, John D., Wallace, Robert B. , Sellers, Thomas A. , Folsom, Aaron R. , Cerhan, James R. , Habermann, Thomas M.

Mayo Clinic

Leukemia & Lymphoma | July 2, 2018 | Volume: 37 | Issue: 3-4 | Pages: 341-349

10.3109/10428190009089434 | PMID 10752985 Get It

Perspectives on Expanded Scope of Practice in Cytotechnology
Friedlander, Maria A., Pineault, Lynnette S. , Roberson, Janie, Spiczka, Amy Wendel

Mayo Clinic

Laboratory Medicine | July 1, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/labmed/lmy042 | PMID 29982577 Get It

Can a Brief Training Session Prepare Physician Sonographers of Differing Experience to Measure the Ischiofemoral Space? A Reliability Study
Boettcher, Brennan J. , Payne, Jeffrey M., Johnson, Adam C. , Finnoff, Jonathan T. , Hollman, John H.

Mayo Clinic

PM&R | June 30, 2018 | Volume: 11 | Issue: 2 | Pages: 142-149

10.1016/j.pmrj.2018.06.014 | PMID 29964210 Get It

ObjectiveThe primary aim of this study was to determine the inter‐ and intrarater reliability of ultrasound (US) measurements of the ischiofemoral space (IFS) following a brief training session. A secondary aim was to determine if reliability correlated with sonographer experience.DesignProspective cohort study.SettingPhysical medicine and rehabilitation department within a tertiary care institution.ParticipantsSeven male and 3 female individuals were recruited to serve as models. Nine physician sonographers (3 postgraduate year [PGY]‐2 residents, 3 PGY‐4 residents, 3 physicians) were recruited to serve as sonographers.Methods or InterventionsSonographers received a 15‐minute educational session on identifying the IFS with US, followed by 20 minutes of practice. Models were then placed in a prone position and secured to prevent hip movement. All operators measured bilateral IFSs in each model twice with a washout period between measurements. Operators were blinded to all measurements.Main Outcome MeasuresPrimary outcomes were inter‐ and intrarater reliability interclass coefficients (ICCs) of IFS measurements among the groups with different levels of US experience. Secondary outcomes included comparisons of inter‐ and intrarater reliability ICCs of IFS measurements between groups, and the difference of mean IFS measurements between groups.ResultsIntrarater reliability ICCs were 0.829, 0.680, and 0.596 for physician, PGY‐4, and PGY‐2 groups, respectively. Interrater reliability ICCs were 0.722, 0.427, and 0.558 for physician, PGY‐4, and PGY‐2 groups, respectively. No statistically significant differences in reliability were identified between groups. Mean IFS measurements were 31.2, 33.4, and 34.0 mm for physician, PGY‐4, and PGY‐2 groups, respectively. Physician measurements were significantly smaller than the PGY‐4 and PGY‐2 measurements (P < .049 and P < .01).ConclusionsFollowing a brief training session, experienced sonographers demonstrated excellent IFS measurement intrarater reliability, whereas PGY‐4 and PGY‐2 sonographers demonstrated fair intrarater reliability. All sonographers demonstrated fair interrater reliability.Level of EvidenceII
Reply to: “Crowell et al. Idiopathic Central Nervous System Inflammatory Disease in the Setting of HLA-B27 Uveitis”
Tobin, W. Oliver , Tobin, W Oliver , Keegan, B. Mark

Mayo Clinic

Ocular Immunology and Inflammation | June 30, 2018 | Volume: 27 | Issue: 6 | Pages: 918-919

10.1080/09273948.2018.1484497 | PMID 29958047 Get It

Systematic review and meta-analysis of the effect of SGLT-2 inhibitors on microvascular outcomes in patients with type 2 diabetes: a review protocol
Dorsey-Treviño, Edgar Gerardo , Contreras-Garza, Belinda Maricela , González‐González, José Gerardo , Álvarez‐Villalobos, Neri Alejandro , Salcido‐Montenegro, Alejandro , González-Colmenero, Alejandro Díaz , González‐Nava, Victoria , Rodriguez‐Tamez, Giselle , Rodríguez‐Gutiérrez, René , Alvarez-Villalobos, Neri, Díaz González-Colmenero, Alejandro, Farrell, Ann M, González-Nava, Victoria, Rodríguez-Tamez, Giselle, Rodríguez-Gutiérrez, René , González-González, José Gerardo , Álvarez-Villalobos, Neri A , Farrell, Ann , Montori, Víctor M.

Mayo Clinic

BMJ Open | June 30, 2018 | Volume: 8 | Issue: 6 | Pages: e020692

10.1136/bmjopen-2017-020692 | PMID 29961013 Get It

Introduction Sodium glucose cotransporter 2 (SGLT-2) inhibitors are a relatively new drug-class of glucose-lowering medications. Several trials and systematic reviews have demonstrated their beneficial effect on some macrovascular outcomes. Their effect on microvascular outcomes has been reported as positive in several trials, however, their effect remains uncertain. Therefore, we report the protocol of a systematic review and meta-analysis aimed at determining the effect of SGLT-2 inhibitors regarding patient-important and surrogate microvascular outcomes in patients with type 2 diabetes. Methods and analysis A comprehensive search will be conducted to find eligible articles from each database’s earliest inception to November 2017. These databases will include Ovid, MEDLINE, EMBASE, Web of Science, and Scopus. We will search for randomized controlled trials (RCTs) that compare any of the SGLT-2 inhibitors with any other active treatment or placebo assessing microvascular outcomes in either their primary or secondary outcomes. Reviewers working independently and in duplicate will review all abstracts, and full-text manuscripts for eligibility, and will systematically extract the data and will assess the risk of bias in the included studies. Random-effects models will also be used. Ethics and dissemination The results of the systematic review will be disseminated via publication in a peer-reviewed journal regardless of outcome and will be presented at relevant conferences. The data we will use do not include individual patient data, so ethical approval is not required PROSPERO registration number CRD42017076460.
Executive summary of AAPM Report Task Group 113: Guidance for the physics aspects of clinical trials
Moran, Jean M. , Molineu, A, Kruse, Jon J. , Jeraj, Robert , Galvin, James M., Palta, Jatinder , Olch, Arthur J. , Oldham, Mark

Mayo Clinic

Journal of Applied Clinical Medical Physics | June 30, 2018 | Volume: 19 | Issue: 5 | Pages: 335-346

10.1002/acm2.12384 | PMID 29959816 Get It

AbstractThe charge of AAPM Task Group 113 is to provide guidance for the physics aspects of clinical trials to minimize variability in planning and dose delivery for external beam trials involving photons and electrons. Several studies have demonstrated the importance of protocol compliance on patient outcome. Minimizing variability for treatments at different centers improves the quality and efficiency of clinical trials. Attention is focused on areas where variability can be minimized through standardization of protocols and processes through all aspects of clinical trials. Recommendations are presented for clinical trial designers, physicists supporting clinical trials at their individual clinics, quality assurance centers, and manufacturers.
Unusual cause of elbow pain in a baseball pitcher
Natwa, Nithin, Zakaria, Alan, Pujalte, George , Pujalte, George G.A. , Pujalte, George G A , Pujalte, George

Mayo Clinic

BMJ Case Reports | June 30, 2018 | Volume: 2018 | Issue: No issue available | Pages: bcr-2018-224287

10.1136/bcr-2018-224287 | PMID 29960959 Get It

An adolescent, right hand-dominant, baseball pitcher presented to sports medicine clinic with posterolateral right elbow pain over 4 months. He rated his pain as 8/10 with pitching, especially at the late cocking phase of throwing. Prior to consult, he had rested 3 months from pitching, progressing to strengthening exercises, with no pain relief. On physical examination, he had 120° of active external rotation, 80° of active internal rotation, mild tenderness to palpation over the capitellum and normal elbow radiography. Magnetic resonance arthrogram of the right elbow revealed subtle, posterolateral joint capsular tear and adjacent synovial hypertrophy. The patient was diagnosed with elbow synovial fold syndrome that was causing impingement at the radiocapitellar joint and was referred to an orthopaedic surgeon. Arthroscopy revealed redundant tissue; scar formation at the radiocapitellar joint was debrided. The patient participated in physical therapy for 2 months and was able to start throwing 3 months later.
GH Therapy in Childhood Cancer Survivors: A Systematic Review and Meta-Analysis
Tamhane, Shrikant , Sfeir, Jad , Kittah, Nana Esi, Jasim, Sina , Chemaitilly, Wassim , Cohen, Laurie E. , Murad, M. Hassan , Sfeir, Jad G, Kittah, Nana Esi N, Murad, M Hassan , Sfeir, Jad G

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | June 29, 2018 | Volume: 103 | Issue: 8 | Pages: 2794-2801

10.1210/jc.2018-01205 | PMID 29982555 Get It

Abstract Background GH deficiency (GHD) is common among childhood cancer survivors (CCSs) with history of tumors, surgery, and/or radiotherapy involving the hypothalamus-pituitary region. We aimed to evaluate the effects of GH therapy (GHT) in CCSs on adult height, risk of diabetes mellitus, abnormal lipids, metabolic syndrome, quality of life, secondary tumors, and disease recurrence. Methods We searched multiple databases for randomized and observational studies. Pairs of reviewers independently selected studies and collected data. Random effects meta-analysis was used to pool outcomes across the studies. Results We included 29 observational studies at moderate to high risk of bias. Sixteen studies compared CCSs on GHT with those not on GHT (512 patients, GH dose: 0.3 to 0.9 IU/kg/week). GHT was significantly associated with height gain [standard deviation score, 0.61; 95% CI, 0.08 to 1.13] and was not significantly associated with the occurrence of secondary tumors [odds ratio (OR), 1.10; 95% CI, 0.72 to 1.67] or tumor recurrence (OR, 0.57; 95% CI, 0.31 to 1.02). Thirteen studies compared CCSs on GHT with normal age- or sex-matched controls or controls with idiopathic GHD or short stature. GHT was associated with either improved or unchanged risk of diabetes, lipid profiles, and metabolic syndrome. GHT was associated with improvements in quality of life. Conclusion CCSs treated with GHT gain height compared with the untreated controls. GHT may improve lipid profiles and quality of life and does not appear to increase the risk of diabetes or the development of secondary tumors, although close monitoring for such complications remains warranted due to uncertainty in the current evidence.